# Palantir Technologies timeline entity: /record/palantir.md id: ent_palantir ## undated - undated | fiscal_year_end | 12-31 | valid | [clm_6EE55AB1EB2C](/claim/clm_6EE55AB1EB2C.md) - undated | cik | 0001321655 | valid | [clm_7B549AC6C4F8](/claim/clm_7B549AC6C4F8.md) - undated | listed_on | Nasdaq | valid | [clm_D67556B8AAE4](/claim/clm_D67556B8AAE4.md) - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_E063BD4C73BD](/claim/clm_E063BD4C73BD.md) - undated | ticker | PLTR | valid | [clm_F8C5887CBC10](/claim/clm_F8C5887CBC10.md) - undated | founder | Alexander C. Karp | unverified | [clm_092BA135F8B9](/claim/clm_092BA135F8B9.md) - undated | industry | data analytics software industry | unverified | [clm_1960FEDC8783](/claim/clm_1960FEDC8783.md) - undated | legal_form | public company | unverified | [clm_4892E7CF0EBB](/claim/clm_4892E7CF0EBB.md) - undated to 2020-01-01 | headquarters | Palo Alto | superseded | [clm_5030B39125A8](/claim/clm_5030B39125A8.md) - undated | country | United States | unverified | [clm_6DC09DE511D2](/claim/clm_6DC09DE511D2.md) - undated | website | https://www.palantir.com/ | unverified | [clm_7BBF031AF882](/claim/clm_7BBF031AF882.md) - undated | founder | Peter Thiel | unverified | [clm_83966AA4032E](/claim/clm_83966AA4032E.md) ## 2003 - 2003-01-01 | founded | 2003-01-01 | valid | [clm_90EE1E2C885D](/claim/clm_90EE1E2C885D.md) ## undated - undated | website | https://www.palantir.com/uk/ | unverified | [clm_AEB182994FC7](/claim/clm_AEB182994FC7.md) - undated | founder | Stephen Cohen | unverified | [clm_BFA4A3BD03D5](/claim/clm_BFA4A3BD03D5.md) - undated | industry | mass surveillance | unverified | [clm_DE55E7DE9913](/claim/clm_DE55E7DE9913.md) - undated | founder | Nathan Gettings | unverified | [clm_EAC31053CE66](/claim/clm_EAC31053CE66.md) ## 2005 - 2005-03-22 | registrant_name | Palantir Technologies Inc. | valid | [clm_4DBEED14A639](/claim/clm_4DBEED14A639.md) ## 2009 - 2009-05-05 | x_username | PalantirTech | unverified | [clm_EAF0927AC12B](/claim/clm_EAF0927AC12B.md) ## 2010 - 2010-12-31 to 2020-03-01 | employees | 313 | superseded | [clm_21C9AC6C9CE2](/claim/clm_21C9AC6C9CE2.md) ## 2017 - 2017-12-31 to 2018-12-31 | total_equity | -1,501,562,000 United States dollar | superseded | [clm_CCCBB1ED5EE3](/claim/clm_CCCBB1ED5EE3.md) ## 2018 - 2018-12-31 to 2019-09-30 | cash_and_equivalents | 1,116,342,000 United States dollar | superseded | [clm_015C6F525A1F](/claim/clm_015C6F525A1F.md) - 2018-12-31 to 2019-12-31 | operating_income | -623,440,000 United States dollar | superseded | [clm_650C63D7E5D6](/claim/clm_650C63D7E5D6.md) - 2018-12-31 to 2019-06-30 | total_equity | -1,751,428,000 United States dollar | superseded | [clm_863F3F335D37](/claim/clm_863F3F335D37.md) - 2018-12-31 to 2019-12-31 | revenue | 595,409,000 United States dollar | superseded | [clm_B56BC2D5FF37](/claim/clm_B56BC2D5FF37.md) - 2018-12-31 to 2019-12-31 | net_income | -580,027,000 United States dollar | superseded | [clm_C0B6ED2D1D25](/claim/clm_C0B6ED2D1D25.md) - 2018-12-31 to 2019-12-31 | research_and_development | 285,451,000 United States dollar | superseded | [clm_DCC4491E32B2](/claim/clm_DCC4491E32B2.md) ## 2019 - 2019-03-25 | x_username | Palantir_FR | unverified | [clm_B43115972191](/claim/clm_B43115972191.md) - 2019-06-30 to 2019-09-30 | total_equity | -1,800,409,000 United States dollar | superseded | [clm_53AAA5E59695](/claim/clm_53AAA5E59695.md) - 2019-09-30 to 2019-12-31 | total_equity | -1,892,590,000 United States dollar | superseded | [clm_6793B4C734EF](/claim/clm_6793B4C734EF.md) - 2019-09-30 to 2020-03-31 | quarterly_operating_income | -144,140,000 United States dollar | superseded | [clm_B5918F842C42](/claim/clm_B5918F842C42.md) - 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 75,880,000 United States dollar | superseded | [clm_D08ABA8D7744](/claim/clm_D08ABA8D7744.md) - 2019-09-30 to 2020-03-31 | quarterly_net_income | -139,860,000 United States dollar | superseded | [clm_EC83FAC49E63](/claim/clm_EC83FAC49E63.md) - 2019-09-30 to 2019-12-31 | cash_and_equivalents | 507,319,000 United States dollar | superseded | [clm_F89E6C70722B](/claim/clm_F89E6C70722B.md) - 2019-12-31 to 2020-12-31 | revenue | 742,555,000 United States dollar | superseded | [clm_32659D097670](/claim/clm_32659D097670.md) - 2019-12-31 to 2020-03-31 | cash_and_equivalents | 1,079,154,000 United States dollar | superseded | [clm_63D0FEEE0EC2](/claim/clm_63D0FEEE0EC2.md) - 2019-12-31 to 2020-12-31 | research_and_development | 305,563,000 United States dollar | superseded | [clm_973F99186600](/claim/clm_973F99186600.md) - 2019-12-31 to 2020-03-31 | total_equity | -1,980,642,000 United States dollar | superseded | [clm_99B5309933CD](/claim/clm_99B5309933CD.md) - 2019-12-31 to 2020-12-31 | operating_income | -576,444,000 United States dollar | superseded | [clm_E159B491984C](/claim/clm_E159B491984C.md) - 2019-12-31 to 2020-09-30 | total_assets | 1,594,025,000 United States dollar | superseded | [clm_F09A78037C43](/claim/clm_F09A78037C43.md) - 2019-12-31 to 2020-12-31 | net_income | -579,646,000 United States dollar | superseded | [clm_F6D8D269661E](/claim/clm_F6D8D269661E.md) ## 2020 - 2020-01-01 to 2026-01-01 | headquarters | Denver | superseded | [clm_9BBA96BD190A](/claim/clm_9BBA96BD190A.md) - 2020-03-01 to 2021-12-31 | employees | 2,500 | superseded | [clm_988B3C500C97](/claim/clm_988B3C500C97.md) - 2020-03-31 to 2020-06-30 | quarterly_operating_income | -70,185,000 United States dollar | superseded | [clm_1D3CD99478CC](/claim/clm_1D3CD99478CC.md) - 2020-03-31 to 2020-06-30 | cash_and_equivalents | 809,530,000 United States dollar | superseded | [clm_5C1E51729221](/claim/clm_5C1E51729221.md) - 2020-03-31 to 2020-06-30 | quarterly_revenue | 229,327,000 United States dollar | superseded | [clm_88815F13C0C7](/claim/clm_88815F13C0C7.md) - 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 65,800,000 United States dollar | superseded | [clm_CD0BD6CEEBCD](/claim/clm_CD0BD6CEEBCD.md) - 2020-03-31 to 2020-06-30 | total_equity | -1,976,619,000 United States dollar | superseded | [clm_DA15AC63DCEB](/claim/clm_DA15AC63DCEB.md) - 2020-03-31 to 2020-06-30 | quarterly_net_income | -54,274,000 United States dollar | superseded | [clm_EABB0751896F](/claim/clm_EABB0751896F.md) - 2020-06-30 to 2020-09-30 | quarterly_operating_income | -99,145,000 United States dollar | superseded | [clm_1F4CD0B9B695](/claim/clm_1F4CD0B9B695.md) - 2020-06-30 to 2020-09-30 | cash_and_equivalents | 1,497,591,000 United States dollar | superseded | [clm_A4AAF6279288](/claim/clm_A4AAF6279288.md) - 2020-06-30 to 2020-09-30 | total_equity | -1,398,701,000 United States dollar | superseded | [clm_B8C8ABEB4890](/claim/clm_B8C8ABEB4890.md) - 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 86,815,000 United States dollar | superseded | [clm_D241AF83430D](/claim/clm_D241AF83430D.md) - 2020-06-30 to 2020-09-30 | quarterly_revenue | 251,889,000 United States dollar | superseded | [clm_E9942B92B1E1](/claim/clm_E9942B92B1E1.md) - 2020-06-30 to 2020-09-30 | quarterly_net_income | -110,455,000 United States dollar | superseded | [clm_FCE0B2892229](/claim/clm_FCE0B2892229.md) - 2020-09-30 to 2020-12-31 | total_assets | 2,603,712,000 United States dollar | superseded | [clm_11D83E136599](/claim/clm_11D83E136599.md) - 2020-09-30 to 2021-03-31 | quarterly_net_income | -853,319,000 United States dollar | superseded | [clm_6855D5AE1951](/claim/clm_6855D5AE1951.md) - 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 313,915,000 United States dollar | superseded | [clm_87753855E2A7](/claim/clm_87753855E2A7.md) - 2020-09-30 to 2021-03-31 | quarterly_operating_income | -847,777,000 United States dollar | superseded | [clm_9A55CEB7588F](/claim/clm_9A55CEB7588F.md) - 2020-09-30 to 2020-12-31 | cash_and_equivalents | 1,800,190,000 United States dollar | superseded | [clm_AD86F629972A](/claim/clm_AD86F629972A.md) - 2020-09-30 to 2020-12-31 | total_equity | 1,251,753,000 United States dollar | superseded | [clm_B70CEE3C06BF](/claim/clm_B70CEE3C06BF.md) - 2020-09-30 to 2021-03-31 | quarterly_revenue | 289,366,000 United States dollar | superseded | [clm_F6D4BF41A839](/claim/clm_F6D4BF41A839.md) - 2020-12-31 to 2021-12-31 | research_and_development | 560,660,000 United States dollar | superseded | [clm_0FB59BA6FECA](/claim/clm_0FB59BA6FECA.md) - 2020-12-31 to 2021-03-31 | cash_and_equivalents | 2,011,323,000 United States dollar | superseded | [clm_25E8A257C12B](/claim/clm_25E8A257C12B.md) - 2020-12-31 to 2021-12-31 | operating_income | -1,173,679,000 United States dollar | superseded | [clm_33406BAA43B7](/claim/clm_33406BAA43B7.md) - 2020-12-31 to 2021-12-31 | net_income | -1,166,391,000 United States dollar | superseded | [clm_59DF4D9CE67B](/claim/clm_59DF4D9CE67B.md) - 2020-12-31 to 2021-03-31 | total_assets | 2,690,504,000 United States dollar | superseded | [clm_60103A7878B7](/claim/clm_60103A7878B7.md) - 2020-12-31 to 2021-12-31 | revenue | 1,092,673,000 United States dollar | superseded | [clm_A862B682D011](/claim/clm_A862B682D011.md) - 2020-12-31 to 2021-03-31 | total_equity | 1,522,550,000 United States dollar | superseded | [clm_CAFAF1B7E920](/claim/clm_CAFAF1B7E920.md) ## 2021 - 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 98,471,000 United States dollar | superseded | [clm_13B8F3742797](/claim/clm_13B8F3742797.md) - 2021-03-31 to 2021-06-30 | total_equity | 1,805,943,000 United States dollar | superseded | [clm_2347CB186390](/claim/clm_2347CB186390.md) - 2021-03-31 to 2021-06-30 | total_assets | 3,014,185,000 United States dollar | superseded | [clm_52BAC1367066](/claim/clm_52BAC1367066.md) - 2021-03-31 to 2021-06-30 | cash_and_equivalents | 2,339,437,000 United States dollar | superseded | [clm_6CFD99AB11A3](/claim/clm_6CFD99AB11A3.md) - 2021-03-31 to 2021-06-30 | quarterly_revenue | 341,234,000 United States dollar | superseded | [clm_8B117D564182](/claim/clm_8B117D564182.md) - 2021-03-31 to 2021-06-30 | quarterly_net_income | -123,474,000 United States dollar | superseded | [clm_92C60556CB3B](/claim/clm_92C60556CB3B.md) - 2021-03-31 to 2021-06-30 | quarterly_operating_income | -114,014,000 United States dollar | superseded | [clm_BF1B4790F2E5](/claim/clm_BF1B4790F2E5.md) - 2021-06-30 to 2021-09-30 | cash_and_equivalents | 2,341,156,000 United States dollar | superseded | [clm_40623A3F18DE](/claim/clm_40623A3F18DE.md) - 2021-06-30 to 2021-09-30 | total_equity | 2,068,963,000 United States dollar | superseded | [clm_7E496F36699A](/claim/clm_7E496F36699A.md) - 2021-06-30 to 2021-09-30 | total_assets | 3,075,668,000 United States dollar | superseded | [clm_84B12A080936](/claim/clm_84B12A080936.md) - 2021-06-30 to 2021-09-30 | quarterly_net_income | -138,580,000 United States dollar | superseded | [clm_A329C5226F84](/claim/clm_A329C5226F84.md) - 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 110,524,000 United States dollar | superseded | [clm_ABCA7490F951](/claim/clm_ABCA7490F951.md) - 2021-06-30 to 2021-09-30 | quarterly_operating_income | -146,148,000 United States dollar | superseded | [clm_D1AC56728328](/claim/clm_D1AC56728328.md) - 2021-06-30 to 2021-09-30 | quarterly_revenue | 375,642,000 United States dollar | superseded | [clm_EA3F262E89FB](/claim/clm_EA3F262E89FB.md) - 2021-09-30 to 2022-03-31 | quarterly_operating_income | -91,941,000 United States dollar | superseded | [clm_1EC8FBD5BFEA](/claim/clm_1EC8FBD5BFEA.md) - 2021-09-30 to 2022-03-31 | quarterly_net_income | -102,137,000 United States dollar | superseded | [clm_20FA31E58D97](/claim/clm_20FA31E58D97.md) - 2021-09-30 to 2022-03-31 | quarterly_revenue | 392,146,000 United States dollar | superseded | [clm_4F6AF14D1439](/claim/clm_4F6AF14D1439.md) - 2021-09-30 to 2021-12-31 | total_equity | 2,248,056,000 United States dollar | superseded | [clm_5BB7F1451171](/claim/clm_5BB7F1451171.md) - 2021-09-30 to 2021-12-31 | cash_and_equivalents | 2,335,068,000 United States dollar | superseded | [clm_97E649423BF0](/claim/clm_97E649423BF0.md) - 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 94,316,000 United States dollar | superseded | [clm_A88C45DDB359](/claim/clm_A88C45DDB359.md) - 2021-09-30 to 2021-12-31 | total_assets | 3,224,327,000 United States dollar | superseded | [clm_C6FE17D64815](/claim/clm_C6FE17D64815.md) - 2021-12-31 to 2022-12-31 | operating_income | -411,046,000 United States dollar | superseded | [clm_4F6ED801FE1D](/claim/clm_4F6ED801FE1D.md) - 2021-12-31 to 2025-12-31 | employees | 2,920 | superseded | [clm_67B37C875723](/claim/clm_67B37C875723.md) - 2021-12-31 to 2022-03-31 | total_equity | 2,291,030,000 United States dollar | superseded | [clm_8739697A37D0](/claim/clm_8739697A37D0.md) - 2021-12-31 to 2022-03-31 | cash_and_equivalents | 2,290,674,000 United States dollar | superseded | [clm_96E11DC8DD07](/claim/clm_96E11DC8DD07.md) - 2021-12-31 to 2022-12-31 | revenue | 1,541,889,000 United States dollar | superseded | [clm_D1D0F7D2A761](/claim/clm_D1D0F7D2A761.md) - 2021-12-31 to 2022-12-31 | net_income | -520,379,000 United States dollar | superseded | [clm_DB960EF76C64](/claim/clm_DB960EF76C64.md) - 2021-12-31 to 2022-03-31 | total_assets | 3,247,450,000 United States dollar | superseded | [clm_F0B047FD0062](/claim/clm_F0B047FD0062.md) - 2021-12-31 to 2022-12-31 | research_and_development | 387,487,000 United States dollar | superseded | [clm_FBC960221493](/claim/clm_FBC960221493.md) ## 2022 - 2022-01-07 | x_username | PalantirPrivacy | unverified | [clm_DF078E3DF5DF](/claim/clm_DF078E3DF5DF.md) - 2022-03-31 to 2022-06-30 | quarterly_net_income | -101,379,000 United States dollar | superseded | [clm_34256CF2BED2](/claim/clm_34256CF2BED2.md) - 2022-03-31 to 2022-06-30 | quarterly_revenue | 446,357,000 United States dollar | superseded | [clm_537C380A1287](/claim/clm_537C380A1287.md) - 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 88,601,000 United States dollar | superseded | [clm_5A30589D5B31](/claim/clm_5A30589D5B31.md) - 2022-03-31 to 2022-06-30 | total_equity | 2,364,746,000 United States dollar | superseded | [clm_6AD226A6F897](/claim/clm_6AD226A6F897.md) - 2022-03-31 to 2022-06-30 | total_assets | 3,319,179,000 United States dollar | superseded | [clm_CB029CCE476C](/claim/clm_CB029CCE476C.md) - 2022-03-31 to 2022-06-30 | quarterly_operating_income | -39,439,000 United States dollar | superseded | [clm_DA7AD79AA745](/claim/clm_DA7AD79AA745.md) - 2022-03-31 to 2022-06-30 | cash_and_equivalents | 2,269,411,000 United States dollar | superseded | [clm_F4D646A42A4A](/claim/clm_F4D646A42A4A.md) - 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 88,171,000 United States dollar | superseded | [clm_0C04D9142E09](/claim/clm_0C04D9142E09.md) - 2022-06-30 to 2022-09-30 | total_assets | 3,282,338,000 United States dollar | superseded | [clm_20AA99537BD7](/claim/clm_20AA99537BD7.md) - 2022-06-30 to 2022-09-30 | quarterly_net_income | -179,329,000 United States dollar | superseded | [clm_3E9F4819CF7F](/claim/clm_3E9F4819CF7F.md) - 2022-06-30 to 2022-09-30 | cash_and_equivalents | 2,358,393,000 United States dollar | superseded | [clm_4F3DF62AEC80](/claim/clm_4F3DF62AEC80.md) - 2022-06-30 to 2022-09-30 | total_equity | 2,348,824,000 United States dollar | superseded | [clm_588E0A9C8AAE](/claim/clm_588E0A9C8AAE.md) - 2022-06-30 to 2022-09-30 | quarterly_operating_income | -41,745,000 United States dollar | superseded | [clm_A0987B2016B8](/claim/clm_A0987B2016B8.md) - 2022-06-30 to 2022-09-30 | quarterly_revenue | 473,010,000 United States dollar | superseded | [clm_A6611FDD3EDA](/claim/clm_A6611FDD3EDA.md) - 2022-09-30 to 2022-12-31 | total_equity | 2,386,615,000 United States dollar | superseded | [clm_147E68767965](/claim/clm_147E68767965.md) - 2022-09-30 to 2023-03-31 | quarterly_revenue | 477,880,000 United States dollar | superseded | [clm_2AE6296415AF](/claim/clm_2AE6296415AF.md) - 2022-09-30 to 2023-03-31 | quarterly_net_income | -123,875,000 United States dollar | superseded | [clm_646C14D32174](/claim/clm_646C14D32174.md) - 2022-09-30 to 2022-12-31 | cash_and_equivalents | 2,411,290,000 United States dollar | superseded | [clm_6F22C246BA90](/claim/clm_6F22C246BA90.md) - 2022-09-30 to 2022-12-31 | total_assets | 3,318,835,000 United States dollar | superseded | [clm_7968A23CBEAD](/claim/clm_7968A23CBEAD.md) - 2022-09-30 to 2023-03-31 | quarterly_operating_income | -62,191,000 United States dollar | superseded | [clm_CB273B35A3E5](/claim/clm_CB273B35A3E5.md) - 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 100,863,000 United States dollar | superseded | [clm_E0C56B111B5F](/claim/clm_E0C56B111B5F.md) - 2022-12-31 to 2023-12-31 | research_and_development | 359,679,000 United States dollar | superseded | [clm_096CC8614865](/claim/clm_096CC8614865.md) - 2022-12-31 to 2023-12-31 | net_income | -373,705,000 United States dollar | superseded | [clm_5E09896ACDD2](/claim/clm_5E09896ACDD2.md) - 2022-12-31 to 2023-12-31 | operating_income | -161,201,000 United States dollar | superseded | [clm_8675A4C21054](/claim/clm_8675A4C21054.md) - 2022-12-31 to 2023-03-31 | cash_and_equivalents | 2,598,540,000 United States dollar | superseded | [clm_8A3BD7133977](/claim/clm_8A3BD7133977.md) - 2022-12-31 to 2023-03-31 | total_assets | 3,461,239,000 United States dollar | superseded | [clm_9964980C7097](/claim/clm_9964980C7097.md) - 2022-12-31 to 2023-03-31 | total_equity | 2,565,326,000 United States dollar | superseded | [clm_BE3584380E10](/claim/clm_BE3584380E10.md) - 2022-12-31 to 2023-12-31 | revenue | 1,905,871,000 United States dollar | superseded | [clm_E48D4635F46A](/claim/clm_E48D4635F46A.md) ## 2023 - 2023-03-31 to 2023-06-30 | total_assets | 3,683,138,000 United States dollar | superseded | [clm_1C2ADF9480F1](/claim/clm_1C2ADF9480F1.md) - 2023-03-31 to 2023-06-30 | quarterly_revenue | 525,186,000 United States dollar | superseded | [clm_3CB3D6CB0444](/claim/clm_3CB3D6CB0444.md) - 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 90,100,000 United States dollar | superseded | [clm_61BCDE87DAC7](/claim/clm_61BCDE87DAC7.md) - 2023-03-31 to 2023-06-30 | cash_and_equivalents | 1,264,738,000 United States dollar | superseded | [clm_9BD5B607D2AA](/claim/clm_9BD5B607D2AA.md) - 2023-03-31 to 2023-06-30 | quarterly_operating_income | 4,115,000 United States dollar | superseded | [clm_CF6A4EA6FA91](/claim/clm_CF6A4EA6FA91.md) - 2023-03-31 to 2023-06-30 | total_equity | 2,723,733,000 United States dollar | superseded | [clm_D02953C6DFC0](/claim/clm_D02953C6DFC0.md) - 2023-03-31 to 2023-06-30 | quarterly_net_income | 16,802,000 United States dollar | superseded | [clm_D7D90FF930B5](/claim/clm_D7D90FF930B5.md) - 2023-06-30 to 2023-09-30 | cash_and_equivalents | 1,055,923,000 United States dollar | superseded | [clm_25BFC51C719B](/claim/clm_25BFC51C719B.md) - 2023-06-30 to 2023-09-30 | quarterly_revenue | 533,317,000 United States dollar | superseded | [clm_6446097851F6](/claim/clm_6446097851F6.md) - 2023-06-30 to 2023-09-30 | quarterly_net_income | 28,127,000 United States dollar | superseded | [clm_6CFEF6A8BAEA](/claim/clm_6CFEF6A8BAEA.md) - 2023-06-30 to 2023-09-30 | total_equity | 2,955,474,000 United States dollar | superseded | [clm_7CADEAE0C6DC](/claim/clm_7CADEAE0C6DC.md) - 2023-06-30 to 2023-09-30 | quarterly_operating_income | 10,074,000 United States dollar | superseded | [clm_7CDCE7CB9EDB](/claim/clm_7CDCE7CB9EDB.md) - 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 99,533,000 United States dollar | superseded | [clm_942B109D558A](/claim/clm_942B109D558A.md) - 2023-06-30 to 2023-09-30 | total_assets | 3,980,264,000 United States dollar | superseded | [clm_CBC6DC4F4E0F](/claim/clm_CBC6DC4F4E0F.md) - 2023-09-30 to 2023-12-31 | cash_and_equivalents | 1,040,310,000 United States dollar | superseded | [clm_1E40E65D9515](/claim/clm_1E40E65D9515.md) - 2023-09-30 to 2024-03-31 | quarterly_operating_income | 39,983,000 United States dollar | superseded | [clm_A3D1FF22A2E3](/claim/clm_A3D1FF22A2E3.md) - 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 105,708,000 United States dollar | superseded | [clm_A671B1044211](/claim/clm_A671B1044211.md) - 2023-09-30 to 2023-12-31 | total_equity | 3,190,015,000 United States dollar | superseded | [clm_BC756C91E2FA](/claim/clm_BC756C91E2FA.md) - 2023-09-30 to 2024-03-31 | quarterly_net_income | 71,505,000 United States dollar | superseded | [clm_D85325DA872D](/claim/clm_D85325DA872D.md) - 2023-09-30 to 2023-12-31 | total_assets | 4,193,417,000 United States dollar | superseded | [clm_DE0803744B0F](/claim/clm_DE0803744B0F.md) - 2023-09-30 to 2024-03-31 | quarterly_revenue | 558,159,000 United States dollar | superseded | [clm_F4DF96D3FBB2](/claim/clm_F4DF96D3FBB2.md) - 2023-12-31 to 2024-03-31 | cash_and_equivalents | 831,047,000 United States dollar | superseded | [clm_31CE5FB4CED3](/claim/clm_31CE5FB4CED3.md) - 2023-12-31 to 2024-03-31 | total_equity | 3,475,561,000 United States dollar | superseded | [clm_40682ED8B60A](/claim/clm_40682ED8B60A.md) - 2023-12-31 to 2024-12-31 | revenue | 2,225,012,000 United States dollar | superseded | [clm_93E912CCCB8E](/claim/clm_93E912CCCB8E.md) - 2023-12-31 to 2024-03-31 | total_assets | 4,522,425,000 United States dollar | superseded | [clm_A2ACDB4A4D0C](/claim/clm_A2ACDB4A4D0C.md) - 2023-12-31 to 2024-12-31 | operating_income | 119,966,000 United States dollar | superseded | [clm_A7421F8EB4BC](/claim/clm_A7421F8EB4BC.md) - 2023-12-31 to 2024-12-31 | research_and_development | 404,624,000 United States dollar | superseded | [clm_B787E5340D6B](/claim/clm_B787E5340D6B.md) - 2023-12-31 to 2024-12-31 | net_income | 209,825,000 United States dollar | superseded | [clm_CEBD81D34832](/claim/clm_CEBD81D34832.md) ## 2024 - 2024-03-31 to 2024-06-30 | quarterly_net_income | 105,530,000 United States dollar | superseded | [clm_1FF99FB8B036](/claim/clm_1FF99FB8B036.md) - 2024-03-31 to 2024-06-30 | total_assets | 4,807,079,000 United States dollar | superseded | [clm_39254945AF34](/claim/clm_39254945AF34.md) - 2024-03-31 to 2024-06-30 | quarterly_operating_income | 80,881,000 United States dollar | superseded | [clm_462A70A93533](/claim/clm_462A70A93533.md) - 2024-03-31 to 2024-06-30 | quarterly_revenue | 634,338,000 United States dollar | superseded | [clm_4D0E39C51B96](/claim/clm_4D0E39C51B96.md) - 2024-03-31 to 2024-06-30 | cash_and_equivalents | 520,388,000 United States dollar | superseded | [clm_B9C7F0ABB7C3](/claim/clm_B9C7F0ABB7C3.md) - 2024-03-31 to 2024-06-30 | total_equity | 3,775,227,000 United States dollar | superseded | [clm_CA57429774F9](/claim/clm_CA57429774F9.md) - 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 110,040,000 United States dollar | superseded | [clm_F3083529EE1B](/claim/clm_F3083529EE1B.md) - 2024-06-30 to 2024-09-30 | quarterly_revenue | 678,134,000 United States dollar | superseded | [clm_5FBAE0F55211](/claim/clm_5FBAE0F55211.md) - 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 108,781,000 United States dollar | superseded | [clm_7967604F24B7](/claim/clm_7967604F24B7.md) - 2024-06-30 to 2024-09-30 | total_assets | 5,191,880,000 United States dollar | superseded | [clm_9CC4E8BA821D](/claim/clm_9CC4E8BA821D.md) - 2024-06-30 to 2024-09-30 | quarterly_operating_income | 105,339,000 United States dollar | superseded | [clm_9D8B20EE20D7](/claim/clm_9D8B20EE20D7.md) - 2024-06-30 to 2024-09-30 | cash_and_equivalents | 512,659,000 United States dollar | superseded | [clm_A6FAC203865C](/claim/clm_A6FAC203865C.md) - 2024-06-30 to 2024-09-30 | quarterly_net_income | 134,126,000 United States dollar | superseded | [clm_ACB80BE5C9A9](/claim/clm_ACB80BE5C9A9.md) - 2024-06-30 to 2024-09-30 | total_equity | 4,050,524,000 United States dollar | superseded | [clm_EE3337D6E68E](/claim/clm_EE3337D6E68E.md) - 2024-09-30 to 2024-12-31 | cash_and_equivalents | 768,710,000 United States dollar | superseded | [clm_3487A203DC94](/claim/clm_3487A203DC94.md) - 2024-09-30 to 2025-03-31 | quarterly_revenue | 725,516,000 United States dollar | superseded | [clm_48986E74FAB7](/claim/clm_48986E74FAB7.md) - 2024-09-30 to 2024-12-31 | total_equity | 4,498,143,000 United States dollar | superseded | [clm_6C40DD742BCF](/claim/clm_6C40DD742BCF.md) - 2024-09-30 to 2024-12-31 | total_assets | 5,768,097,000 United States dollar | superseded | [clm_99C8D4D442C3](/claim/clm_99C8D4D442C3.md) - 2024-09-30 to 2025-03-31 | quarterly_operating_income | 113,140,000 United States dollar | superseded | [clm_AD30356A9B10](/claim/clm_AD30356A9B10.md) - 2024-09-30 to 2025-03-31 | quarterly_net_income | 143,525,000 United States dollar | superseded | [clm_B169476D1437](/claim/clm_B169476D1437.md) - 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 117,555,000 United States dollar | superseded | [clm_DEB8FD703E02](/claim/clm_DEB8FD703E02.md) - 2024-12-31 to 2025-03-31 | cash_and_equivalents | 2,098,524,000 United States dollar | superseded | [clm_4CD82233B56C](/claim/clm_4CD82233B56C.md) - 2024-12-31 to 2025-12-31 | net_income | 462,190,000 United States dollar | superseded | [clm_58EC1A06D4BE](/claim/clm_58EC1A06D4BE.md) - 2024-12-31 to 2025-12-31 | operating_income | 310,403,000 United States dollar | superseded | [clm_5BDDE2326FC3](/claim/clm_5BDDE2326FC3.md) - 2024-12-31 to 2025-03-31 | total_assets | 6,340,884,000 United States dollar | superseded | [clm_6E85EB033328](/claim/clm_6E85EB033328.md) - 2024-12-31 to 2025-03-31 | total_equity | 5,003,275,000 United States dollar | superseded | [clm_E01E3610BEC4](/claim/clm_E01E3610BEC4.md) - 2024-12-31 to 2025-12-31 | revenue | 2,865,507,000 United States dollar | superseded | [clm_F4B50DD5C5D7](/claim/clm_F4B50DD5C5D7.md) - 2024-12-31 to 2025-12-31 | research_and_development | 507,878,000 United States dollar | superseded | [clm_FE81FD6F5ED8](/claim/clm_FE81FD6F5ED8.md) ## 2025 - 2025-03-31 to 2025-06-30 | cash_and_equivalents | 993,464,000 United States dollar | superseded | [clm_0482CB314FB8](/claim/clm_0482CB314FB8.md) - 2025-03-31 to 2025-06-30 | total_assets | 6,736,917,000 United States dollar | superseded | [clm_5080796543A3](/claim/clm_5080796543A3.md) - 2025-03-31 to 2025-06-30 | total_equity | 5,424,155,000 United States dollar | superseded | [clm_72568465780B](/claim/clm_72568465780B.md) - 2025-03-31 to 2025-06-30 | quarterly_revenue | 883,855,000 United States dollar | superseded | [clm_AD844F531664](/claim/clm_AD844F531664.md) - 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 134,889,000 United States dollar | superseded | [clm_BF808097B4BF](/claim/clm_BF808097B4BF.md) - 2025-03-31 to 2025-06-30 | quarterly_net_income | 214,031,000 United States dollar | superseded | [clm_E9CE877E7B2C](/claim/clm_E9CE877E7B2C.md) - 2025-03-31 to 2025-06-30 | quarterly_operating_income | 176,048,000 United States dollar | superseded | [clm_FC15AC53223E](/claim/clm_FC15AC53223E.md) - 2025-04-11 | owned_by | BlackRock | unverified | [clm_22F91060432B](/claim/clm_22F91060432B.md) - 2025-04-11 | owned_by | The Vanguard Group | unverified | [clm_4A86DE527658](/claim/clm_4A86DE527658.md) - 2025-04-11 | owned_by | Peter Thiel | unverified | [clm_9EDD730FC5FC](/claim/clm_9EDD730FC5FC.md) - 2025-04-11 | owned_by | Alexander C. Karp | unverified | [clm_F5BB48DD5038](/claim/clm_F5BB48DD5038.md) - 2025-06-30 to 2025-09-30 | quarterly_operating_income | 269,317,000 United States dollar | superseded | [clm_21E6112A6CAF](/claim/clm_21E6112A6CAF.md) - 2025-06-30 to 2025-09-30 | total_equity | 5,928,901,000 United States dollar | superseded | [clm_798605D32794](/claim/clm_798605D32794.md) - 2025-06-30 to 2025-09-30 | cash_and_equivalents | 929,547,000 United States dollar | superseded | [clm_91E82FDDA5A1](/claim/clm_91E82FDDA5A1.md) - 2025-06-30 to 2025-09-30 | quarterly_revenue | 1,003,697,000 United States dollar | superseded | [clm_AD0643E7B29A](/claim/clm_AD0643E7B29A.md) - 2025-06-30 to 2025-09-30 | total_assets | 7,365,688,000 United States dollar | superseded | [clm_DA8D80470BDA](/claim/clm_DA8D80470BDA.md) - 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 135,043,000 United States dollar | superseded | [clm_DBD622BC8348](/claim/clm_DBD622BC8348.md) - 2025-06-30 to 2025-09-30 | quarterly_net_income | 326,727,000 United States dollar | superseded | [clm_F6A47EF8E9AD](/claim/clm_F6A47EF8E9AD.md) - 2025-09-30 to 2025-12-31 | total_assets | 8,113,960,000 United States dollar | superseded | [clm_054C2ED539E8](/claim/clm_054C2ED539E8.md) - 2025-09-30 to 2026-03-31 | quarterly_operating_income | 393,256,000 United States dollar | superseded | [clm_0627B2F745E2](/claim/clm_0627B2F745E2.md) - 2025-09-30 to 2026-03-31 | quarterly_revenue | 1,181,092,000 United States dollar | superseded | [clm_8A8689CF4A54](/claim/clm_8A8689CF4A54.md) - 2025-09-30 to 2025-12-31 | cash_and_equivalents | 1,615,967,000 United States dollar | superseded | [clm_97B4B5F4C768](/claim/clm_97B4B5F4C768.md) - 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 144,191,000 United States dollar | superseded | [clm_B830AECE547C](/claim/clm_B830AECE547C.md) - 2025-09-30 to 2025-12-31 | total_equity | 6,590,457,000 United States dollar | superseded | [clm_C4759DEF63BE](/claim/clm_C4759DEF63BE.md) - 2025-09-30 to 2026-03-31 | quarterly_net_income | 475,599,000 United States dollar | superseded | [clm_FC664B16E51F](/claim/clm_FC664B16E51F.md) - 2025-12-31 | employees | 4,429 | valid | [clm_41542329910D](/claim/clm_41542329910D.md) - 2025-12-31 | revenue | 4,475,446,000 United States dollar | valid | [clm_43A19D1AA10F](/claim/clm_43A19D1AA10F.md) - 2025-12-31 to 2026-03-31 | total_assets | 8,900,392,000 United States dollar | superseded | [clm_56802E1435CF](/claim/clm_56802E1435CF.md) - 2025-12-31 | operating_income | 1,414,015,000 United States dollar | valid | [clm_6E8EDBD23248](/claim/clm_6E8EDBD23248.md) - 2025-12-31 | net_income | 1,625,033,000 United States dollar | valid | [clm_7068991BD392](/claim/clm_7068991BD392.md) - 2025-12-31 to 2026-03-31 | cash_and_equivalents | 1,423,796,000 United States dollar | superseded | [clm_98D7F8F2E821](/claim/clm_98D7F8F2E821.md) - 2025-12-31 | research_and_development | 557,677,000 United States dollar | valid | [clm_A2C560F477AC](/claim/clm_A2C560F477AC.md) - 2025-12-31 to 2026-03-31 | total_equity | 7,387,268,000 United States dollar | superseded | [clm_BD14CF072646](/claim/clm_BD14CF072646.md) ## 2026 - 2026-03-31 to 2026-06-30 | total_equity | 8,449,663,000 United States dollar | superseded | [clm_3B0E9DE34DC4](/claim/clm_3B0E9DE34DC4.md) - 2026-03-31 to 2026-06-30 | quarterly_revenue | 1,632,583,000 United States dollar | superseded | [clm_4FDDE1D66CBF](/claim/clm_4FDDE1D66CBF.md) - 2026-03-31 to 2026-06-30 | cash_and_equivalents | 2,291,631,000 United States dollar | superseded | [clm_5AADD4FD53AD](/claim/clm_5AADD4FD53AD.md) - 2026-03-31 to 2026-06-30 | total_assets | 10,199,183,000 United States dollar | superseded | [clm_D426FAA47D35](/claim/clm_D426FAA47D35.md) - 2026-03-31 to 2026-06-30 | quarterly_net_income | 870,527,000 United States dollar | superseded | [clm_D68DD7A87399](/claim/clm_D68DD7A87399.md) - 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 160,981,000 United States dollar | superseded | [clm_EA9CBDD05ADE](/claim/clm_EA9CBDD05ADE.md) - 2026-03-31 to 2026-06-30 | quarterly_operating_income | 753,998,000 United States dollar | superseded | [clm_F4A58DC08B67](/claim/clm_F4A58DC08B67.md) - 2026-04-22 | feature_added | Dossier translation mode | valid | [clm_F2CC82F7A7FE](/claim/clm_F2CC82F7A7FE.md) - 2026-04-30 | partnership | NHS England | valid | [clm_3821887EE909](/claim/clm_3821887EE909.md) - 2026-06-08 | feature_added | Elasticsearch reindex tooling | valid | [clm_1D65307805CD](/claim/clm_1D65307805CD.md) - 2026-06-30 | quarterly_net_income | 1,061,890,000 United States dollar | valid | [clm_2486EB3D20C6](/claim/clm_2486EB3D20C6.md) - 2026-06-30 | cash_and_equivalents | 2,030,047,000 United States dollar | valid | [clm_486AD66C9AB8](/claim/clm_486AD66C9AB8.md) - 2026-06-30 | total_equity | 9,774,194,000 United States dollar | valid | [clm_6413EF904455](/claim/clm_6413EF904455.md) - 2026-06-30 | total_assets | 11,678,564,000 United States dollar | valid | [clm_65AAAA5821CB](/claim/clm_65AAAA5821CB.md) - 2026-06-30 | quarterly_revenue | 1,935,464,000 United States dollar | valid | [clm_6E941C6073C7](/claim/clm_6E941C6073C7.md) - 2026-06-30 | quarterly_research_and_development | 192,513,000 United States dollar | valid | [clm_CF0E2E11F633](/claim/clm_CF0E2E11F633.md) - 2026-06-30 | quarterly_operating_income | 912,004,000 United States dollar | valid | [clm_DA50745D65CE](/claim/clm_DA50745D65CE.md) - 2026-08-20 | released | Security Forge | valid | [clm_2F851AA4C098](/claim/clm_2F851AA4C098.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.